ONPH is exploring strategic partnerships and opportunities in oncology

Our Portfolio (Licences - LOI)

Nanosmart Pharmaceuticals  -  
NanoSmart's® platform technology  (US  Patent No: 7,799,327 and EU 1706145 B1)

Connect2Med

Social engagement and retention platform for clinical trials

Licences
logo.98142257_logo.png